National Institute of Allergy and Infectious Diseases, National Institutes of Health

NIAID Research Funding

NIAID Funding News

Opportunities and Announcements

Budget and Funding

Grants

Contracts
About NIAID R&D Contracts
R&D Requests for Proposals
Standard Operating Procedures
Contracts Links
Training and Career
Contact Information

Standard Operating Procedures

Questions and Answers

Advisory Council

Glossary of Funding and Policy Terms

Find It! A-Z

Latest Updates

Archived R&D RFPs and Amendments -- 2002

For other years, see the Archived R&D RFPs index. You can also see current NIAID R&D RFPs.

ID No.	Full RFP Number, Title, and Amendments	Open Date	Close Date
03-31	RFP-NIH-NIAID-DAIT-03-31, Immune Epitope Database and Analysis Program Amendment #1, 2002-10-18 Amendment #2, 2002-11-06	2002-08-29	2002-11-26
03-32	RFP-NIH-NIAID-DMID-03-32, Antibody Production Facility Amendment #1, 2002-10-16 Amendment #2, 2002-10-24 Amendment #3, 2002-10-25 Amendment #4, 2002-11-05 Amendment #5, 2002-11-25	2002-09-20	2002-12-20
03-33	RFP-NIH-NIAID-DMID-03-33, DMID Clinical Trials Management Amendment #1, 2002-11-27	2002-10-10	2003-01-07
03-34	RFP-NIH-NIAID-DMID-03-34, Biodefense and Emerging Infections Research Resources Program Amendment #1, 2003-02-05 Amendment #2, 2003-02-19	2002-12-09	2003-03-20
03-36	BAA-NIH-NIAID-NCRR-DMID-03-36, Regional Biocontainment Laboratories (RBL) and National Biocontainment Laboratories (NBL) Amendment #1, Q&A, revised 2003-02-04 Amendment #2, 2003-02-04 Amendment #3, 2002-12-31	2002-12-31	2003-02-10
03-37	RFP-NIH-NIAID-DMID-03-37, Respiratory Pathogens Reference Laboratory Support	2002-07-25	2002-11-18
03-38	RFP-NIH-NIAID-DMID-BAA-03-38, Biodefense Proteomics Research Programs: Identifying Targets for Therapeutic Interventions Using Proteomic Technology Amendment #1, Q&A, 2003-03-24 Amendment # 2, 2003-02-19 Amendment #3, 2003-03-24 Amendment #4, 2003-05-05 Amendment #5, 2003-06-20	2002-12-16	2003-09-15
03-39	RFP-NIH-NIAID-DMID-03-39, In Vitro and Animal Models for Emerging Diseases and Biodefense Amendment #1, 2002-12-18 Amendment #2, 2003-01-15 Amendment #3, 2003-01-22 Amendment #4, 2003-09-26	2002-09-30	2003-02-04
03-41	RFP-NIH-NIAID-DAIT-BAA-03-41, Innate Immune Receptors and Adjuvant Discovery Amendment #1, 2002-11-22	2002-09-30	2003-01-07
03-43	RFP-NIH-NIAID-DAIT-03-43, Large Scale Antibody and T Cell Epitope Discovery Program Amendment #1, 2002-11-21	2002-10-28	2003-01-21
03-44	RFP-NIH-NIAID-DMID-03-44, Development and Testing of a Modified Vaccinia Ankara (MVA) Vaccine Amendment #1, 2002-09-04 Amendment #2, 2002-09-23	2002-08-15	2002-09-30
03-45	RFP-NIH-NIAID-DMID-03-45, Administrative Resource for Biodefense Proteomic Centers Amendment #1, 2002-12-31 Amendment #2, 2003-02-19 Amendment #3, Q&A, 2003-07-05 Amendment #4, 2003-04-18	2002-12-12	2003-09-15
03-04	RFP-NIH-NIAID-DMID-03-04, Food and Waterborne Diseases Integrated Research Network Amendment #1, 2002-09-06 Amendment #2, 2002-11-04 Amendment #3, 2002-11-06 Amendment #4, 2002-11-06	2002-07-29	2002-11-18
03-05	RFP-NIH-NIAID-DMID-03-05, Basic and Clinical Approaches to Controlling Human Respiratory Pathogens Amendment #1, 2002-09-17] Amendment #2, 2002-10-15	2002-07-25	2002-11-18
03-06	RFP-NIH-NIAID-DMID-03-06, In Vitro Antiviral Screening Program Amendment #1, 2002-10-18 Amendment #2, 2002-11-21 Amendment #3, 2002-12-13	2002-09-30	2003-01-15
03-08	RFP-NIH-NIAID-DMID-03-08, Clinical Trials for Antiviral Therapies Amendment #1, 2002-10-28	2002-09-04	2002-11-15
03-09	RFP-NIH-NIAID-DMID-03-09, New Animal Models for: Part A Tuberculosis (TB) and Part B Invasive Aspergillosis (IA) Amendment #1, 2002-07-09 Amendment #2, 2002-07-29 Amendment #3, 2002-07-29	2002-05-02	2002-08-12
03-10	RFP-NIH-NIAID-DMID-03-10, Network for Large-Scale Sequencing of Microbial Genomes Amendment #1, 2003-02-04	2002-11-26	2003-02-18
03-12	RFP NIH-NIAID-DAIDS-03-12, HIV Vaccine Design and Development Teams Frequently Asked Questions, 2002-03-15	2002-03-15	2002-07-01
03-13	RFP-NIH-NIAID-DAIDS-03-13, HLA Typing and Epitope Mapping Relative to HIV Vaccine Design Amendment #1, 2002-08-29 Amendment #2, 2002-08-30 Amendment #3, 2002-09-27 Amendment #4, 2002-10-03	2002-05-30	2002-09-16
03-18	RFP Draft NIH-NIAID-DAIDS-03-18, MASTER CONTRACT for PRECLINICAL DEVELOPMENT	2002-03-18	2002-04-15
03-21	RFP-NIH-NIAID-DAIDS-03-21, Pharmacokinetics & Pharmacodynamics of Antimicrobials in Animal Models Amendment#1, 2002-11-22	2002-09-30	2003-01-22
03-22	RFP-NIH-NIAID-DAIT-03-22, Primary Immunodeficiency Disease (PID) Consortium Amendment #1, 2002-10-16	2002-08-13	2003-01-06
03-25	RFP-NIH-NIAID-DAIDS-03-25, HIV Clinical Research Management Support Admendment #1, 2002-08-13 Amendment #2, 2002-08-15	2002-07-22	2002-10-22
03-26	RFP NIH-NIAID-DAIDS-03-26, Regulatory Compliance Center Amendment #1, 2002-05-22	2002-03-29	2002-07-15
03-28	RFP-NIH-NIAID-DMID-03-28, Food & Waterborne Diseases Integrated Research Network: Coordinating and Biostatistics Center Amendment #1, 2002-11-08 Amendment #2, 2002-11-18	2002-07-29	2002-12-02
03-01	RFP NIH-NIAID-DAIDS-03-01, Reagent Resource Support for AIDS Vaccine Development Amendment #1, 2002-03-21 Amendment #2, 2002-03-22 Amendment #3, 2002-03-28	2002-03-14	2002-06-14
02-23	RFP NIH-NIAID-DAIT-02-23, Statistical and Clinical Coordinating Center for Autoimmune Disease Clinical Trials (SACCC-ADCT) Amendment #1, 2002-03-04	2002-01-04	2002-03-18
02-26	RFP NIH-NIAID-DMID-02-26, Development and Testing of Vaccines Against Anthrax Amendment #1, 2002-05-28 Amendment #2, 2002-06-03	2002-04-22	2002-06-06

For other years, see the Archived R&D RFPs index. You can also see current NIAID R&D RFPs.

Return to the main R&D Contracts Web page.

Look It Up

See the Glossary for more terms.